ANDA 88959, held by ANI Pharmaceuticals. Procainamide Hydrochloride.
As of Nov 21, 2026, ANDA 88959 (Procainamide Hydrochloride), held by ANI Pharmaceuticals, was first approved by FDA on Dec 2, 1985, with 10 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 2, 1985 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Procainamide Hydrochloride500MG · tablet, extended release;oral | Procainamide Hydrochloride | Discontinued |
| May 11, 1994 | Supplement 12Manufacturing | Approved | None posted |
| Dec 22, 1992 | Supplement 9Manufacturing | Approved | None posted |
| Dec 22, 1992 | Supplement 11Manufacturing | Approved | None posted |
| Mar 4, 1992 | Supplement 10Labeling | Approved | None posted |
| Mar 4, 1992 | Supplement 13Labeling | Approved | None posted |
| Feb 17, 1989 | Supplement 6Labeling | Approved | None posted |
| Jan 5, 1989 | Supplement 8Manufacturing | Approved | None posted |
| May 2, 1988 | Supplement 7Manufacturing | Approved | None posted |
| Feb 26, 1986 | Supplement 1Manufacturing | Approved | None posted |
| Feb 26, 1986 | Supplement 3Manufacturing | Approved | None posted |
| Dec 2, 1985 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters